Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis

BACKGROUND: Treatment of GT3 remains challenging compared to other genotypes. AIMS: To explore real life SVR rates and to identify predictors of virological failure across the most recently used Direct acting antiviral (DAA) regimens in a large cohort of Italian patients with cirrhosis or advanced f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangia, Alessandra, Losappio, Ruggero, Cenderello, Giovanni, Potenza, Domenico, Mazzola, Michele, De Stefano, Giulio, Terreni, Natalia, Copetti, Massimiliano, Minerva, Nicola, Piazzola, Valeria, Bacca, Donato, Palmieri, Vincenzo, Sogari, Fernando, Santoro, Rosanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067691/
https://www.ncbi.nlm.nih.gov/pubmed/30063745
http://dx.doi.org/10.1371/journal.pone.0200568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067691/
https://www.ncbi.nlm.nih.gov/pubmed/30063745
http://dx.doi.org/10.1371/journal.pone.0200568

Ejemplares similares